Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL

Evaluation of the ARKRAY HA-8190V instrument for HbA1c

(2021) Eline A.E. van der Hagen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL

(2021) Koshi Akahane et al.   Blood Advances

Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL

(2020) Atsushi Watanabe et al.   BLOOD

Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma

(2020) Mitsuto Hanihara et al.   Clinical Epigenetics

Epigenetic silencing affects L-asparaginase sensitivity and predicts outcome in T-ALL

(2019) Aurore Touzart et al.   CLINICAL CANCER RESEARCH

Novel method for DNA methylation analysis using high-performance liquid chromatography and its clinical application

(2018) Takuya Yotani et al.   CANCER SCIENCE

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus

(2016) Kjeld Schmiegelow et al.   LANCET ONCOLOGY

Asparaginase-associated toxicity in children with acute lymphoblastic leukemia

(2015) Nobuko Hijiya et al.   LEUKEMIA & LYMPHOMA

Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

(2015) Ute Fischer et al.   NATURE GENETICS

Postinduction Dexamethasone and Individualized Dosing ofEscherichia ColiL-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

(2013) Lynda M. Vrooman et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials

(2013) Anthony V. Moorman et al.   JOURNAL OF CLINICAL ONCOLOGY

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

(2013) Mark R. Gilbert et al.   JOURNAL OF CLINICAL ONCOLOGY

Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia

(2011) J. D. Kawedia et al.   BLOOD